SEC 13F Intelligence

Mass General Brigham, Inc / PLRX

Mass General Brigham, Inc’s Pliant Therapeutics Inc Position

Does Mass General Brigham, Inc own Pliant Therapeutics Inc (PLRX)? Not currently — the last reported position was 288.7K shares worth $3M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q3 2024
Shares
288.7K
% of Portfolio
+7.42%
Quarters Held
3
position exited

Position History PLRX

Reported value by quarter
Q1 ’24: $4MQ1 ’24Q2 ’24: $3MQ2 ’24Q3 ’24: $3MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024288.7K$3M+7.42%
Q2 2024288.7K$3M+15.11%
Q1 2024288.7K$4M+7.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mass General Brigham, Inc’s full portfolio or all institutional holders of PLRX.